Cwm LLC Purchases 6,704 Shares of Align Technology, Inc. $ALGN

Cwm LLC grew its position in Align Technology, Inc. (NASDAQ:ALGNFree Report) by 50.5% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 19,975 shares of the medical equipment provider’s stock after acquiring an additional 6,704 shares during the period. Cwm LLC’s holdings in Align Technology were worth $2,501,000 at the end of the most recent reporting period.

A number of other large investors have also bought and sold shares of the business. Rothschild Investment LLC grew its holdings in shares of Align Technology by 140.3% during the second quarter. Rothschild Investment LLC now owns 149 shares of the medical equipment provider’s stock worth $28,000 after purchasing an additional 87 shares during the last quarter. True Wealth Design LLC grew its holdings in Align Technology by 7,650.0% during the 2nd quarter. True Wealth Design LLC now owns 155 shares of the medical equipment provider’s stock worth $29,000 after acquiring an additional 153 shares during the last quarter. Cromwell Holdings LLC increased its position in Align Technology by 2,900.0% in the 2nd quarter. Cromwell Holdings LLC now owns 180 shares of the medical equipment provider’s stock valued at $34,000 after acquiring an additional 174 shares in the last quarter. CYBER HORNET ETFs LLC bought a new position in shares of Align Technology in the second quarter worth about $36,000. Finally, MUFG Securities EMEA plc acquired a new position in shares of Align Technology during the second quarter worth approximately $38,000. 88.43% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on the stock. Zacks Research upgraded shares of Align Technology from a “strong sell” rating to a “hold” rating in a research report on Tuesday, September 30th. Wall Street Zen upgraded Align Technology from a “hold” rating to a “buy” rating in a research report on Saturday. Morgan Stanley upped their price target on Align Technology from $142.00 to $154.00 and gave the company an “equal weight” rating in a research note on Thursday, October 30th. Jefferies Financial Group boosted their price objective on Align Technology from $140.00 to $155.00 in a report on Thursday, October 30th. Finally, Evercore ISI reduced their target price on shares of Align Technology from $220.00 to $170.00 and set an “outperform” rating on the stock in a research note on Tuesday, November 25th. One research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $172.18.

Get Our Latest Stock Report on Align Technology

Align Technology Stock Performance

Shares of NASDAQ ALGN opened at $156.03 on Friday. Align Technology, Inc. has a 52-week low of $122.00 and a 52-week high of $237.23. The stock has a market cap of $11.20 billion, a P/E ratio of 30.24, a P/E/G ratio of 1.76 and a beta of 1.83. The firm has a 50 day moving average price of $148.38 and a 200 day moving average price of $152.70.

Align Technology (NASDAQ:ALGNGet Free Report) last posted its earnings results on Wednesday, October 29th. The medical equipment provider reported $2.61 earnings per share for the quarter, topping the consensus estimate of $2.38 by $0.23. Align Technology had a net margin of 9.50% and a return on equity of 13.96%. The company had revenue of $995.69 million for the quarter, compared to analyst estimates of $980.75 million. During the same period last year, the business posted $2.35 earnings per share. The business’s revenue for the quarter was up 1.8% compared to the same quarter last year. Analysts predict that Align Technology, Inc. will post 7.98 earnings per share for the current fiscal year.

Align Technology Profile

(Free Report)

Align Technology, Inc (NASDAQ: ALGN) pioneered the use of digital technology in orthodontics through the development of the Invisalign system, a series of clear, removable aligners that provide an alternative to traditional metal braces. Since its founding in 1997 by Zia Chishti and Kelsey Wirth, the Tempe, Arizona–based company has expanded its focus to include intraoral scanners, CAD/CAM software for dental laboratories and comprehensive digital dentistry solutions.

The company’s signature Invisalign system leverages 3D imaging and computer-aided design (CAD) to create customized aligners that gradually reposition teeth, improving patient comfort and treatment predictability.

Featured Stories

Want to see what other hedge funds are holding ALGN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Align Technology, Inc. (NASDAQ:ALGNFree Report).

Institutional Ownership by Quarter for Align Technology (NASDAQ:ALGN)

Receive News & Ratings for Align Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology and related companies with MarketBeat.com's FREE daily email newsletter.